secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibikase Therapeutics, Inc. (IKT)
CIK:        0001750149
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001193125-24-158318
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Inhibikase shareholders approve equity plan increase; charter amendment fails
-----------------------------------------------------------------------------

- Milton H. Werner re-elected with 2,993,996 votes for, 100,914 withheld.
- Ratification of CohnReznick as auditor passed with 4,352,312 for, 21,268 against.
- Amendment to 2020 Equity Incentive Plan (increase of 2.5M shares) approved with 2,706,691 for.
- Proposal to eliminate 66 2/3% vote requirement for charter amendments failed (2,929,207 for, 120,362 against).
- All results include substantial broker non-votes on director election and equity plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750149/000119312524158318/0001193125-24-158318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750149/000119312524158318/d850029d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer